Related Experiment Video
Updated: Nov 24, 2025

09:08
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.9K
Single Cell Transcriptomics Implicate Novel Monocyte and T Cell Immune Dysregulation in Sarcoidosis
Lori Garman1, Richard C Pelikan1, Astrid Rasmussen1
1Oklahoma Medical Research Foundation, Genes and Human Disease, Oklahoma City, OK, United States.
Frontiers in Immunology
|December 28, 2020
Summary
This study reveals persistent immune cell activation in sarcoidosis, identifying specific monocyte and T cell dysregulation. These findings highlight novel therapeutic targets for this systemic inflammatory disease.
Area of Science:
- Immunology
- Genomics
- Systemic inflammatory diseases
Background:
- Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation.
- Previous studies using mixed cell populations lacked cell-type-specific insights into immune dysregulation.
Purpose of the Study:
- To perform the first single-cell RNA-sequencing study on peripheral immune cells in sarcoidosis.
- To identify cell-type-specific immune dysregulation and novel inflammatory pathways in sarcoidosis patients.
Main Methods:
- Single-cell RNA-sequencing of peripheral immune cells from 48 sarcoidosis patients and controls.
- Unbiased clustering to identify cell types and differentially expressed genes.
- Bioinformatic assessment of gene function, pathway enrichment, and predictive modeling.
Main Results:
- Persistent activation of circulating classical monocytes with upregulation of trafficking molecules and enrichment of HMGB1, mTOR, and ephrin receptor signaling pathways.
- Dysregulation in T cell subsets, including CD4 naïve T cells (apoptosis, Th17/Treg differentiation) and effector T cells (anergy pathways).
- Identification of dysfunctional p53, cell death, and TNFR2 signaling in regulatory T cells.
Conclusions:
- Novel cell-type-specific inflammatory and regulatory pathways identified in sarcoidosis.
- Proposed model of sarcoidosis immunopathology involving hyperactivated innate/adaptive immunity, Treg dysfunction, and T cell anergy.
- Identification of potential novel therapeutic targets for sarcoidosis.

